Your browser doesn't support javascript.
loading
Construction and Preclinical Evaluation of a 124/125I-Labeled Specific Antibody Targeting PD-L2 in Lung Cancer.
Yao, Yuan; Hou, Xingguo; Liu, Song; Liu, Teli; Ren, Yanan; Ma, Xiaokun; Zhang, Qian; Wang, Pei; Guo, Qian; Ma, Xiaopan; Yang, Zhi; Zhu, Hua; Li, Nan.
Afiliación
  • Yao Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Hou X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Liu S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Liu T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Ren Y; Guizhou University School of Medicine, Guiyang, 550025 Guizhou, People's Republic of China.
  • Ma X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Zhang Q; Guizhou University School of Medicine, Guiyang, 550025 Guizhou, People's Republic of China.
  • Wang P; Guizhou University School of Medicine, Guiyang, 550025 Guizhou, People's Republic of China.
  • Guo Q; Guizhou University School of Medicine, Guiyang, 550025 Guizhou, People's Republic of China.
  • Ma X; Guizhou University School of Medicine, Guiyang, 550025 Guizhou, People's Republic of China.
  • Yang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Zhu H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
  • Li N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, No. 52 Fu-Cheng Rd., 100142 Beijing, People's Republic of China.
Mol Pharm ; 20(2): 1365-1374, 2023 02 06.
Article en En | MEDLINE | ID: mdl-36579764
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article